Kriya Therapeutics, Inc, a provider of novel technologies and therapeutics in gene therapy, has secured $100 million in Series B financing. Patient Square Capital led the round.
Source: Press Release
Kriya Therapeutics lands $100m Series B
Kriya Therapeutics, Inc, a provider of novel technologies and therapeutics in gene therapy, has secured $100 million in Series B financing.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: